Inhibition of KDEL receptors remodels the tumor microenvironment for robust T cell independent tumor regression
Tirosh, B.; Pattanayak, S. P.; Wang, H.; Willard, B.; Chan, T.; Merrick, W. C.; Lu, Z.-R.
Show abstract
Tumor immunotherapy is supported by low-grade inflammatory conditions at the microenvironment, triggered by immunogenic cell death (ICD). However, ICD is dampened when tumors acquire resistance, affecting immune recognition. KDEL receptors (KDELRs), through a retrograde Golgi-to-ER transport, prevent spontaneous secretion of KDEL proteins. We report that inhibition of a single KDELR in a minor fraction of tumor cells, primarily KDELR2, provokes robust infiltration of macrophages and neutrophils into the tumor microenvironment, resulting in a complete regression of both immunogenic and non-immunogenic tumors independently of T cells. Importantly, in the course of regression, anti-tumor T cells are primed, conferring protection against a second challenge. Recapitulated by intratumoral delivery of siDKELR2 utilizing lipid nanoparticles, we implicate KDELR2 as a target to unleash an unusual robust innate immune response, which represents a tractable approach to initiate an adaptive response downstream, bypassing conventional ICD-inducing therapies. We propose KDELR targeting as a strategy to improve immunotherapy across tumor types, including "cold" tumors resistant to T cell-based immunotherapies.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Tumor-derived extracellular vesicles regulate tumor-infiltrating regulatory T cells via the immunoreceptor CD300a 96%
- Metastatic Single Tumor Cells Evade NK Cell-mediated Killing by Thrombin-mediated Loss of the Activating Ligand CD155/PVR/Necl-5 96%
- Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen specific tumor cell killing by cytotoxic T cells 96%
Similar papers in this journal
- Immune modulation of innate and adaptive responses restores immune surveillance and establishes anti-tumor immunological memory 96%
- T cell-mediated development of stromal fibroblasts with an immune-enhancing chemokine profile 96%
- Inflammasome- and gasdermin D-independent IL-1β production mobilizes neutrophils to inhibit antitumor immunity 95%
Similar papers in this journal
- Integrin αvβ8 on T cells is responsible for suppression of anti-tumor immunity in multiple syngeneic models and is a promising target for tumor immunotherapy 96%
- Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment 96%
- A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivation 96%
Similar papers in this journal
Similar papers in this journal
- MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer 95%
- The spontaneous neoantigen-specific CD4+ T cell response to a growing tumor is functionally and phenotypically diverse. 95%
- Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.